Carregant...

Systemic and intravesical adoptive cell therapy of tumor-reactive T cells can decrease bladder tumor growth in vivo

BACKGROUND: The therapeutic armamentarium of bladder cancer has been recently enriched with the introduction of new therapies including immune checkpoint inhibitors, receptor tyrosine kinase inhibitors and antibody drug conjugates, however treatment responses and duration of responses are still less...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunother Cancer
Autors principals: Bunch, Brittany L, Morse, Jennifer, Asby, Sarah, Blauvelt, Jamie, Aydin, Ahmet M, Innamarato, Patrick, Hajiran, Ali, Beatty, Matthew, Poch, Michael, Pilon-Thomas, Shari
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7733200/
https://ncbi.nlm.nih.gov/pubmed/33303579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001673
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!